Dihydropyrimidines sustain aggressive cancer states by stabilizing DPYSL2
Hayashi, A.; Knapp-Goldin, S.; Karmi, A.; Gupta, V.; Mizrahi, I.; Lavi, S.; Shammah, S.; Sitton, Y.; Glukhman, R.; Solaimuthu, B.; Banerjee, S.; Abu Rmaileh, A.; Khatib, A.; Lichtenstein, M.; Schueler-Furman, O.; Wiener, R.; Shaul, Y. D.
Show abstract
Cancer cell states are governed by coordinated signaling and metabolic networks, yet the mechanisms coupling metabolic activity to oncogenic signaling remain poorly understood. Here, we identify dihydropyrimidines (DHPs), metabolites generated during pyrimidine catabolism, as "signaling metabolites" that sustain aggressive cancer cell states. Depletion of DHPs, either by knockout of the pyrimidine catabolic enzyme DPYD or by expression of the DHP-degrading enzyme DPYS, suppressed STAT3 signaling and attenuated mesenchymal and inflammatory transcriptional programs. Mechanistically, DHPs stabilized DPYSL2, a JAK1-interacting adaptor protein required for efficient STAT3 activation. Structural modeling and thermal stability analyses further support a direct interaction between DHPs and DPYSL2. Accordingly, high DPYD expression was associated with EMT, inflammatory signaling, and poor-prognosis breast cancer subtypes across patient cohorts. Ultimately, our findings establish pyrimidine catabolism as a direct regulator of signaling competence and identify DHPs as signaling-active metabolites that couple cellular metabolic state to oncogenic transcriptional programs and mesenchymal identity.
Matching journals
The top 5 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- A recurrent pathogenic BRCA2 truncating variant reveals a role for BRCA2-PCAF complex in modulating NF-κB-driven transcription 97%
- Suppression of HSF1 activity by wildtype p53 creates the driving force for p53 loss-of-heterozygosity, enabling mutant p53 stabilization and invasion 96%
- A novel non-catalytic scaffolding activity of Hexokinase 2 contributes to EMT and metastasis 96%
Similar papers in this journal
- ALDH1A3-acetaldehyde metabolism potentiates transcriptionalheterogeneity in melanoma 96%
- SF3B1 promotes tumor malignancy through splicing-independent co-activation of HIF1α 95%
- PERK-dependent reciprocal crosstalk between ER and non-centrosomal microtubules coordinates ER architecture and cell shape 95%
Similar papers in this journal
Similar papers in this journal
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.